Recently, silencing of PTGFRN in glioma cells in vitro downregulates cell proliferation, migration, invasion, cell cycle progression, and apoptosis, suggesting its oncogenic role in gliomas [27]. This evidence concerns the gene PTGFRN and central nervous system cancer.